EU/496
WTO/TBT
CE European Union
  • 13 - Environment and health protection, Safety
  • 71 - Chemical technology
2017-09-27
2017-08-07

Substances recently classified as carcinogenic, mutagenic and reproductive toxicants (CMR) category 1A and 1B as substances on their own or in mixtures that are placed on the market or used for supply to the general public.

Draft Commission Regulation amending the Appendices to Annex XVII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) as regards CMR substances (3 pages + Annex 4 pages, in English)

This draft Commission Regulation proposes to include within the scope of entries 28 to 30 of Annex XVII to Regulation (EC) No 1907/2006 the substances listed below, with the effect of restricting their placing on the market or use for supply to the general public as substances on their own, as constituents of other substances or in mixtures and to impose the requirement to mark packaging with the label "restricted to professional users". This is consequent on the recent classification of these substances as CMR category 1A or 1B under Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, as amended by Commission Regulation (EU) 2017/776.

The substances are: 2,3-epoxypropyl methacrylate; glycidyl methacrylate; cadmium carbonate; cadmium hydroxide; cadmium dihydroxide; cadmium nitrate; cadmium dinitrate; Anthraquinone; N,N'-methylenedimorpholine; N,N'-methylenebismorpholine; [formaldehyde released from N,N'-methylenebismorpholine][MBM]; reaction products of paraformaldehyde and 2-hydroxypropylamine (ratio 3:2); [formaldehyde released from 3,3'-methylenebis[5-methyloxazolidine]; formaldehyde released from oxazolidin] [MBO]; reaction products of paraformaldehyde with 2-hydroxypropylamine (ratio 1:1); [formaldehyde released from α,α,α-trimethyl-1,3,5-triazine-1,3,5(2H,4H,6H)-triethanol] [HPT]; methylhydrazine; cadmium carbonate; cadmium hydroxide; cadmium dihydroxide; cadmium nitrate; cadmium dinitrate; 2-methyl-1-(4-methylthiophenyl)-2-morpholinopropan-1-one; 2,3-epoxypropyl methacrylate; glycidyl methacrylate; cyproconazole (ISO); (2RS,3RS;2RS,3SR)-2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol; dibutyltin dilaurate; dibutyl[bis(dodecanoyloxy)]stannane; nonadecafluorodecanoic acid [1]; ammonium nonadecafluorodecanoate [2]; sodium nonadecafluorodecanoate [3]; triadimenol (ISO); (1RS,2RS;1RS,2SR)-1-(4-chlorophenoxy)-3,3-dimethyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol;α-tert-butyl-β-(4-chlorophenoxy)-1H-1,2,4-triazole-1-ethanol; quinolin-8-ol; 8-hydroxyquinoline; thiacloprid (ISO); (Z)-3-(6-chloro-3-pyridylmethyl)-1,3-thiazolidin-2-ylidenecyanamide; {(2Z)-3-[(6-chloropyridin-3-yl)methyl]-1,3-thiazolidin-2-ylidene}cyanamide; carbetamide (ISO); (R)-1-(ethylcarbamoyl)ethyl carbanilate; (2R)-1-(ethylamino)-1-oxopropan-2-yl phenylcarbamate.

The substance formaldehyde ...%, which was classified as a carcinogen category 1B by Commission Regulation (EU) No 605/2014, is also now included within the scope of entries 28 to 30 of Annex XVII to REACH.